Philip L. Hooper

3.2k total citations
65 papers, 2.1k citations indexed

About

Philip L. Hooper is a scholar working on Ophthalmology, Physiology and Molecular Biology. According to data from OpenAlex, Philip L. Hooper has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 16 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in Philip L. Hooper's work include Retinal Diseases and Treatments (13 papers), Heat shock proteins research (12 papers) and Glaucoma and retinal disorders (9 papers). Philip L. Hooper is often cited by papers focused on Retinal Diseases and Treatments (13 papers), Heat shock proteins research (12 papers) and Glaucoma and retinal disorders (9 papers). Philip L. Hooper collaborates with scholars based in United States, Canada and Hungary. Philip L. Hooper's co-authors include Paul L. Hooper, László Vı́gh, Henry J. Kaplan, Michael Tytell, Narsing A. Rao, Ronald E. Smith, Tom Sheidow, Ibolya Horváth, Anna G. Holmes and Graeme I. Lancaster and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Philip L. Hooper

63 papers receiving 2.0k citations

Peers

Countries citing papers authored by Philip L. Hooper

Since Specialization

Citations

This map shows the geographic impact of Philip L. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Hooper more than expected).

Fields of papers citing papers by Philip L. Hooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip L. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Hooper. The network helps show where Philip L. Hooper may publish in the future.

Co-authorship network of co-authors of Philip L. Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Hooper. A scholar is included among the top collaborators of Philip L. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Hooper. Philip L. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Higher blood lipid levels after the transition to menopause in two forager-horticulturalist populations 2025 ·Evolution Medicine and Public Health ·Malcolm Getz, (unknown), (unknown), (unknown), Jesús Vázquez, Nicole Appel, Margaret Gatz, (unknown), Philip L. Hooper, Bret Beheim, Kenneth H. Buetow, Caleb E. Finch, Gregory S. Thomas, Jonathan Stieglitz, Michael Gurven, Hillard Kaplan, Benjamin C. Trumble	0
2	COVID-19 and heme oxygenase: novel insight into the disease and potential therapies 2020 ·Cell Stress and Chaperones ·Philip L. Hooper	49
3	New Surgeon Outcomes and the Effectiveness of Surgical Training 2017 ·Ophthalmology ·Chaim M. Bell, Sherif El-Defrawy, Sudeep S. Gill, Marlo Whitehead, (unknown), Philip L. Hooper, Martin ten Hove	26
4	Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy 2017 ·Canadian Journal of Ophthalmology ·Philip L. Hooper, Marie Carole Boucher, Alan F. Cruess, Keith Dawson, (unknown), Mark Greve, V Kozousek, Wai‐Ching Lam, David Maberley	13
5	Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period 2017 ·Eye ·(unknown), Philip L. Hooper, Tom Sheidow, John R. Gonder, (unknown), (unknown), William Hodge, Subrata Chakrabarti, Cindy Hutnik	2
6	The central role of heat shock factor 1 in synaptic fidelity and memory consolidation 2016 ·Cell Stress and Chaperones ·Philip L. Hooper, Heather D. Durham, Zsolt Török, Paul L. Hooper, Tim Crul, László Vı́gh	31
7	An acute bout of whole body passive hyperthermia increases plasma leptin, but does not alter glucose or insulin responses in obese type 2 diabetics and healthy adults 2016 ·Journal of Thermal Biology ·Eric Rivas, (unknown), Craig G. Crandall, Philip L. Hooper, Vic Ben‐Ezra	18
8	Effect of cataract surgery volume constraints on recently graduated ophthalmologists: a population-based cohort study 2016 ·Canadian Medical Association Journal ·Chaim M. Bell, Sherif El-Defrawy, Sudeep S. Gill, Philip L. Hooper, Marlo Whitehead, (unknown), (unknown), (unknown), Martin ten Hove	7
9	Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies 2014 ·Metabolic Syndrome and Related Disorders ·Botond Literáti-Nagy, Kálmán Tory, Barna Peitl, Ágnes Bajza, László Korányi, (unknown), Philip L. Hooper, László Vı́gh, Zoltán Szilvássy	33
10	Induction of Heat Shock Proteins in the Therapy of Type 2 Diabetes and Metabolic Syndrome 2014 ·EBioMedicine ·Philip L. Hooper	4
11	The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes 2014 ·Cell Stress and Chaperones ·Philip L. Hooper, Gábor Balogh, Eric Rivas, Kylie Kavanagh, László Vı́gh	81
12	Contemporary Management of Diabetic Retinopathy in Canada: From Guidelines to Algorithm Guidance 2013 ·Ophthalmologica ·Philip L. Hooper, (unknown), Kevin Colleaux, Alan F. Cruess, Mark Greve, Wai‐Ching Lam, (unknown), Éric Tourville	8
13	Loss of stress response as a consequence of viral infection: implications for disease and therapy 2012 ·Cell Stress and Chaperones ·Philip L. Hooper, Lawrence E. Hightower, Paul L. Hooper	20
14	Combination Therapy in Neovascular Age-Related Macular Degeneration (amd): A Three-Armed, Randomized, Prospective Clinical Trial of Low Fluence Photodynamic Therapy (rpdt) With Adjunctive Avastin and Triamcinolone Acetonide (Kenalog)(Triple Therapy) versus Rpdt With Adjunctive Avastin (Double Therapy) versus Monotherapy With Avastin 2009 ·Investigative Ophthalmology & Visual Science ·Tom Sheidow, Philip L. Hooper, Peter J. Kertes, C. Schwartz, David Maberley, (unknown), Brad J. Hinz, Mark Greve, Matthew Tennant, (unknown)	1
15	HSP72 protects against obesity-induced insulin resistance 2008 ·Proceedings of the National Academy of Sciences ·Jason Chung, (unknown), Darren C. Henstridge, Anna G. Holmes, Stanley M. H. Chan, José Luis Mesa Mesa, Graeme I. Lancaster, Robert J. Southgate, Clinton R. Bruce, Stephen J. Duffy, Ibolya Horváth, Ruben Mestril, Matthew J. Watt, Philip L. Hooper, Bronwyn A. Kingwell, László Vı́gh, Andrea L. Hevener, Mark A. Febbraio	425
16	Visudyne Anti-VEGF Combination Therapy (VACT): A Multicentred, Retrospective Clinical Practice Review of Combination Therapy in AMD 2007 ·Investigative Ophthalmology & Visual Science ·Philip L. Hooper, Tom Sheidow	1
17	Insulin Signaling, GSK-3, Heat Shock Proteins and the Natural History of Type 2 Diabetes Mellitus: A Hypothesis 2007 ·Metabolic Syndrome and Related Disorders ·Philip L. Hooper	35
18	Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins 2001 ·Trials ·Philip L. Hooper	3
19	The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study 1997 ·British Journal of Urology ·Philip L. Hooper, Douglas G. Tincello, D. H. RICHMOND	14
20	Zinc and vitamin A 1980 ·American Journal of Clinical Nutrition ·Philip L. Hooper, Philip J. Garry, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact